The synergistic linking of increasing health and wealth is broadly accepted - it's an integral part of the thinking between the Sustainable Development Goals, and the World Bank's call for universal healthcare as a way of boosting a country's economy.

But the quantification of that link - the extent to which a particular health intervention, has broader economic impacts, is actually pretty poorly understood.

In this podcast, we hear from some economists, who have an idea about how we could - fairly easily - measure those impacts at the same time we measure clinical efficacy.

Joining us are, Dean Jamison, professor emeritus of global health at the University of Washington
Osondu Ogbuoji, assistant research professor at Duke Global Health Insitute.
Till Bärnighausen, director of the Heidelberg Institute of Global Health
Sebastian Vollmer, professor of development economics at the University of Göttingen

The collection that prompted this discussion is "Health, Wealth and Profits" - https://www.bmj.com/health-wealth-profits